Otsuka : appoints Board Members and Audit & Supervisory Board Members (192KB)
March 27, 2020 at 03:58 am EDT
Share
March 27, 2020
Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members
Otsuka Holdings Co., Ltd., (Head office: Chiyoda-ku, Tokyo, Japan; President and Representative
Director, CEO: Tatsuo Higuchi) announced the board members and audit & supervisory board members as detailed below were ratified today at the annual general shareholders' meeting and a meeting of its Board of Directors.
Board Members and Audit & Supervisory Board Members
Name
Title
Ichiro Otsuka
Chairman and Representative Director
Tatsuo Higuchi
President and Representative Director, CEO
Yoshiro Matsuo
Senior Managing Director
Yuko Makino
Executive Director, CFO
Shuichi Takagi
Executive Director, Business Portfolio Management
Sadanobu Tobe
Executive Director
Masayuki Kobayashi
Executive Director
Noriko Tojo
Executive Director
Makoto Inoue
Executive Director
(new appointment)
Yukio Matsutani
Outside Director
Ko Sekiguchi
Outside Director
Yoshihisa Aoki
Outside Director
Mayo Mita
Outside Director
(new appointment)
Yozo Toba
Standing Audit & Supervisory Board Member
Hiroshi Sugawara
Outside Audit & Supervisory Board Member
Yoko Wachi
Outside Audit & Supervisory Board Member
Kazuo Takahashi
Outside Audit & Supervisory Board Member
*Atsumasa Makise retired as executive director.
Attachments
Original document
Permalink
Disclaimer
Otsuka Holdings Co. Ltd. published this content on 27 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 March 2020 07:57:05 UTC
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
OTSUKA HOLDINGS CO., LTD. 
